These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23896325)

  • 1. Tadalafil-induced tonic-clonic seizures in a 23-year-old man.
    Calabrò RS; Reitano S; Bramanti P
    Epilepsy Behav; 2013 Sep; 28(3):519-20. PubMed ID: 23896325
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serous central chorioretinopathy and tadalafil: a case report].
    Nadeau S; Nguyen F; Guigou S
    J Fr Ophtalmol; 2012 Feb; 35(2):121.e1-5. PubMed ID: 21680058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subarachnoid hemorrhage associated with tadalafil.
    Sheikh-Taha M; Alaywa RA
    Am J Health Syst Pharm; 2011 Jul; 68(13):1195-6. PubMed ID: 21690423
    [No Abstract]   [Full Text] [Related]  

  • 4. Tadalafil: visual and auditory disorders. Inform patients of these risks.
    Prescrire Int; 2011 Nov; 20(121):267. PubMed ID: 22066316
    [No Abstract]   [Full Text] [Related]  

  • 5. Leber's hereditary optic neuropathy precipitated by tadalafil use for erectile dysfunction.
    Cornish KS; Barras C
    Semin Ophthalmol; 2011 Jan; 26(1):7-10. PubMed ID: 21275598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tadalafil and benign prostatic hypertrophy. Too risky.
    Prescrire Int; 2014 Apr; 23(148):96. PubMed ID: 24860894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke after tadalafil use.
    Cannizzaro E; Cannizzaro C; Lopez G; Lo Coco D
    Neurol Sci; 2013 Oct; 34(10):1843-4. PubMed ID: 23385684
    [No Abstract]   [Full Text] [Related]  

  • 8. Central serous chorioretinopathy following oral tadalafil.
    Gordon-Bennett P; Rimmer T
    Eye (Lond); 2012 Jan; 26(1):168-9. PubMed ID: 22056864
    [No Abstract]   [Full Text] [Related]  

  • 9. Tadalafil (Cialis) for signs and symptoms of benign prostatic hyperplasia.
    Med Lett Drugs Ther; 2011 Nov; 53(1377):89-90. PubMed ID: 22075669
    [No Abstract]   [Full Text] [Related]  

  • 10. Hearing loss with phosphodiesterase-5 inhibitors: a prospective and objective analysis with tadalafil.
    Thakur JS; Thakur S; Sharma DR; Mohindroo NK; Thakur A; Negi PC
    Laryngoscope; 2013 Jun; 123(6):1527-30. PubMed ID: 23553123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stiff fingers as an unwanted side effect of intravascular tadalafil gel abuse.
    Vaughan EM; Yeung D; West CC; Tadros A; Curnier A
    Ann R Coll Surg Engl; 2014 Mar; 96(2):e19-20. PubMed ID: 24780660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute, bilateral, concurrent central retinal artery occlusion in sickle cell disease after use of tadalafil (Cialis).
    Murthy RK; Perez L; Priluck JC; Grover S; Chalam KV
    JAMA Ophthalmol; 2013 Nov; 131(11):1471-3. PubMed ID: 24052082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic PDE-5 inhibition in patients with erectile dysfunction - a treatment approach using tadalafil once-daily.
    Porst H; Hell-Momeni K; Büttner H
    Expert Opin Pharmacother; 2012 Jul; 13(10):1481-94. PubMed ID: 22725705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed drug eruption caused by tadalafil--case report.
    Bjekic M; Markovic M; Sipetic S
    An Bras Dermatol; 2013; 88(4):617-9. PubMed ID: 24068137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral knee and intermittent elbow pain in a competitive archer/hunter: phosphodiesterase-5-inhibitor-statin interaction?
    Pujalte GG; Acosta L
    Clin J Sport Med; 2014 Sep; 24(5):e52-3. PubMed ID: 24231931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of phosphodiesterase-5 inhibitor tadalafil in Eisenmenger syndrome--a randomized, placebo-controlled, double-blind crossover study.
    Mukhopadhyay S; Nathani S; Yusuf J; Shrimal D; Tyagi S
    Congenit Heart Dis; 2011; 6(5):424-31. PubMed ID: 21914136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tadalafil: a phosphodiesterase-5 inhibitor for benign prostatic hyperplasia.
    Cantrell MA; Baye J; Vouri SM
    Pharmacotherapy; 2013 Jun; 33(6):639-49. PubMed ID: 23529917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transient global amnesia after tadalafil use].
    Bardés I; Pujadas F; Ibarria M; Boada M
    Med Clin (Barc); 2008 Jun; 131(2):78. PubMed ID: 18588835
    [No Abstract]   [Full Text] [Related]  

  • 19. Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension.
    Arif SA; Poon H
    Clin Ther; 2011 Aug; 33(8):993-1004. PubMed ID: 21762988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.
    Brock G; Broderick G; Roehrborn CG; Xu L; Wong D; Viktrup L
    BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.